568 related articles for article (PubMed ID: 33881820)
1. Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents.
Du Z; Li M; Ren J; Qu X
Acc Chem Res; 2021 May; 54(9):2172-2184. PubMed ID: 33881820
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
Han J; Du Z; Lim MH
Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
[TBL] [Abstract][Full Text] [Related]
3. Recent Progress in the Drug Development for the Treatment of Alzheimer's Disease Especially on Inhibition of Amyloid-peptide Aggregation.
Liu Y; Cong L; Han C; Li B; Dai R
Mini Rev Med Chem; 2021; 21(8):969-990. PubMed ID: 33245270
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory Activity Of Curcumin Derivatives Towards Metal-free And Metal-induced Amyloid-β Aggregation.
Kochi A; Lee HJ; Vithanarachchi SM; Padmini V; Allen MJ; Lim MH
Curr Alzheimer Res; 2015; 12(5):415-23. PubMed ID: 25938870
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Novel Multifunctional Ligand for Simultaneous Inhibition of Amyloid-Beta (Aβ
Asadbegi M; Shamloo A
ACS Chem Neurosci; 2019 Nov; 10(11):4619-4632. PubMed ID: 31566950
[TBL] [Abstract][Full Text] [Related]
6. Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.
Rana M; Sharma AK
Metallomics; 2019 Jan; 11(1):64-84. PubMed ID: 30234208
[TBL] [Abstract][Full Text] [Related]
7. The Pathogenesis Mechanism, Structure Properties, Potential Drugs and Therapeutic Nanoparticles against the Small Oligomers of Amyloid-β.
Wang K; Na L; Duan M
Curr Top Med Chem; 2021; 21(2):151-167. PubMed ID: 32938351
[TBL] [Abstract][Full Text] [Related]
8. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
9. Ability of selenium species to inhibit metal-induced Aβ aggregation involved in the development of Alzheimer's disease.
Vicente-Zurdo D; Romero-Sánchez I; Rosales-Conrado N; León-González ME; Madrid Y
Anal Bioanal Chem; 2020 Sep; 412(24):6485-6497. PubMed ID: 32322953
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Aβ aggregates in Alzheimer's disease by epigallocatechin and epicatechin-3-gallate from green tea.
Chen T; Yang Y; Zhu S; Lu Y; Zhu L; Wang Y; Wang X
Bioorg Chem; 2020 Dec; 105():104382. PubMed ID: 33137558
[TBL] [Abstract][Full Text] [Related]
11. Exploring the potential of pyrazoline containing molecules as Aβ aggregation inhibitors in Alzheimer's disease.
Khambete MP; Khare LP; Kapadia AB; Degani MS
Drug Metab Pers Ther; 2020 Aug; 35(3):. PubMed ID: 32776895
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
Behl T; Kaur I; Fratila O; Brata R; Bungau S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
[TBL] [Abstract][Full Text] [Related]
13. Breaker peptides against amyloid-β aggregation: a potential therapeutic strategy for Alzheimer's disease.
Ghosh N; Kundu LM
Future Med Chem; 2021 Oct; 13(20):1767-1794. PubMed ID: 34498978
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation and molecular modeling of benzofuran piperidine derivatives as Aβ antiaggregant.
Chowdhury SR; Gu J; Hu Y; Wang J; Lei S; Tavallaie MS; Lam C; Lu D; Jiang F; Fu L
Eur J Med Chem; 2021 Oct; 222():113541. PubMed ID: 34116326
[TBL] [Abstract][Full Text] [Related]
15. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
16. Conjugation of RTHLVFFARK to human lysozyme creates a potent multifunctional modulator for Cu
Li X; Wang W; Dong X; Sun Y
J Mater Chem B; 2020 Mar; 8(11):2256-2268. PubMed ID: 32100783
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of human serum albumin on Cu-induced Aβ(40) aggregation and toxicity.
Lu N; Yang Q; Li J; Tian R; Peng YY
Eur J Pharmacol; 2015 Nov; 767():160-4. PubMed ID: 26463036
[TBL] [Abstract][Full Text] [Related]
18. Multi-target-directed triazole derivatives as promising agents for the treatment of Alzheimer's disease.
Kaur A; Mann S; Kaur A; Priyadarshi N; Goyal B; Singhal NK; Goyal D
Bioorg Chem; 2019 Jun; 87():572-584. PubMed ID: 30928879
[TBL] [Abstract][Full Text] [Related]
19. Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.
Dai X; Hou W; Sun Y; Gao Z; Zhu S; Jiang Z
Int J Mol Sci; 2015 May; 16(5):10526-36. PubMed ID: 26006224
[TBL] [Abstract][Full Text] [Related]
20. d-Enantiomeric RTHLVFFARK-NH
Liu W; Dong X; Sun Y
ACS Chem Neurosci; 2019 Mar; 10(3):1390-1401. PubMed ID: 30650306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
